Analyst Expectations For Phreesia's Future

In the last three months, 6 analysts have published ratings on Phreesia PHR, offering a diverse range of perspectives from bullish to bearish.

The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 3 2 1 0 0
Last 30D 1 0 1 0 0
1M Ago 1 1 0 0 0
2M Ago 1 0 0 0 0
3M Ago 0 1 0 0 0

Insights from analysts' 12-month price targets are revealed, presenting an average target of $31.67, a high estimate of $37.00, and a low estimate of $28.00. Observing a downward trend, the current average is 6.85% lower than the prior average price target of $34.00.

price target chart

Investigating Analyst Ratings: An Elaborate Study

The perception of Phreesia by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.

Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target
Robert Simmons DA Davidson Maintains Neutral $32.00 $32.00
Richard Close Canaccord Genuity Raises Buy $37.00 $36.00
Joe Goodwin JMP Securities Maintains Market Outperform $28.00 -
Jailendra Singh Truist Securities Announces Buy $35.00 -
Ryan MacDonald Needham Maintains Buy $29.00 -
Stephanie Davis Barclays Announces Overweight $29.00 -

Key Insights:

  • Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Phreesia. This information offers a snapshot of how analysts perceive the current state of the company.
  • Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Phreesia compared to the broader market.
  • Price Targets: Analysts predict movements in price targets, offering estimates for Phreesia's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.

Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Phreesia's market position. Stay informed and make well-informed decisions with our Ratings Table.

Stay up to date on Phreesia analyst ratings.

If you are interested in following small-cap stock news and performance you can start by tracking it here.

Delving into Phreesia's Background

Phreesia Inc is a provider of comprehensive software solutions that improves the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, but not limited to, initial patient contact, registration, appointment scheduling, payments, and post-appointment patient surveys.

Unraveling the Financial Story of Phreesia

Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.

Revenue Growth: Phreesia's remarkable performance in 3 months is evident. As of 31 October, 2023, the company achieved an impressive revenue growth rate of 25.33%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Health Care sector.

Net Margin: Phreesia's net margin is impressive, surpassing industry averages. With a net margin of -34.86%, the company demonstrates strong profitability and effective cost management.

Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of -12.49%, the company showcases effective utilization of equity capital.

Return on Assets (ROA): Phreesia's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -8.93%, the company may face hurdles in achieving optimal financial returns.

Debt Management: With a below-average debt-to-equity ratio of 0.05, Phreesia adopts a prudent financial strategy, indicating a balanced approach to debt management.

The Significance of Analyst Ratings Explained

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.

Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.

Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst RatingsBZI-AAR
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!